SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lupus flare prevention drug trial halted early
Disease control TerminatedThis study tested a drug called PRV-3279 to see if it could prevent lupus flares in people with active systemic lupus erythematosus (SLE). The trial included 28 adults with moderate to severe lupus who had improved after steroid treatment. The study was terminated early, so resul…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Lupus drug combo study halted early: only 12 patients enrolled
Disease control TerminatedThis study tested two lupus treatments—mycophenolate mofetil alone or with voclosporin—in people with moderately severe lupus. Researchers wanted to see if matching treatments to patients' immune system types could improve results. The study was stopped early and only enrolled 12…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC
-
Lupus drug trial halted early: what happened with telitacicept?
Disease control TerminatedThis study tested whether the drug telitacicept could help control lupus symptoms better than a placebo. It included 91 people aged 12 to 70 with moderate-to-severe lupus. The trial was stopped early, so results are limited. The goal was to see if the drug could reduce disease ac…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Study explores vaccine protection in patients on Immune-Suppressing meds
Knowledge-focused TerminatedThis study aimed to measure how well the COVID-19 vaccine triggers an immune response in people with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers planned to enroll 78 adults, but the study was stopped early. The goal was to understand …
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC